Coreen Oei

468 total citations
7 papers, 232 citations indexed

About

Coreen Oei is a scholar working on Immunology, Molecular Biology and Virology. According to data from OpenAlex, Coreen Oei has authored 7 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Virology. Recurrent topics in Coreen Oei's work include Toxin Mechanisms and Immunotoxins (3 papers), Peptidase Inhibition and Analysis (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Coreen Oei is often cited by papers focused on Toxin Mechanisms and Immunotoxins (3 papers), Peptidase Inhibition and Analysis (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Coreen Oei collaborates with scholars based in United States, France and United Kingdom. Coreen Oei's co-authors include Theodore F. Logan, Michael J. Robertson, Steven J. Kathman, Jill Weisenbach, James W. Mier, Linda M. Thurmond, Lini Pandite, Henry Koon, Roxanne C. Jewell and Kent J. Weinhold and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and AIDS Research and Human Retroviruses.

In The Last Decade

Coreen Oei

7 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Coreen Oei United States	5	152	101	82	28	24	7	232
Richard Wnek United States	10	141 0.9×	89 0.9×	143 1.7×	24 0.9×	26 1.1×	14	284
C. Huber Germany	6	305 2.0×	148 1.5×	160 2.0×	19 0.7×	28 1.2×	10	397
Catherine McIntyre United Kingdom	8	150 1.0×	117 1.2×	78 1.0×	26 0.9×	20 0.8×	12	277
Natalie J. Neubert Switzerland	5	151 1.0×	56 0.6×	114 1.4×	14 0.5×	13 0.5×	6	224
Lauren B. Banks United States	5	80 0.5×	83 0.8×	68 0.8×	19 0.7×	14 0.6×	11	190
Christelle Capini France	7	267 1.8×	72 0.7×	36 0.4×	14 0.5×	20 0.8×	9	383
Fernanda Castro United Kingdom	6	145 1.0×	89 0.9×	64 0.8×	8 0.3×	19 0.8×	8	242
Christine Stemmer France	8	226 1.5×	102 1.0×	108 1.3×	21 0.8×	28 1.2×	10	352
Jenifer Widger United States	6	235 1.5×	93 0.9×	136 1.7×	16 0.6×	11 0.5×	11	309
Thil Batuwangala United Kingdom	6	135 0.9×	114 1.1×	31 0.4×	18 0.6×	30 1.3×	8	266

Countries citing papers authored by Coreen Oei

Since Specialization

Citations

This map shows the geographic impact of Coreen Oei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coreen Oei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coreen Oei more than expected).

Fields of papers citing papers by Coreen Oei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Coreen Oei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coreen Oei. The network helps show where Coreen Oei may publish in the future.

Co-authorship network of co-authors of Coreen Oei

This figure shows the co-authorship network connecting the top 25 collaborators of Coreen Oei. A scholar is included among the top collaborators of Coreen Oei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Coreen Oei. Coreen Oei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Zauderer, Marjorie G., Peter W. Szlosarek, Sylvestre Le Moulec, et al.. (2018). Phase 2, multicenter study of the EZH2 inhibitor tazemetostat as monotherapy in adults with relapsed or refractory (R/R) malignant mesothelioma (MM) with BAP1 inactivation.. Journal of Clinical Oncology. 36(15_suppl). 8515–8515. 38 indexed citations

Robertson, Michael J., James W. Mier, Theodore F. Logan, et al.. (2006). Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer. Clinical Cancer Research. 12(14). 4265–4273. 126 indexed citations

Robertson, Michael J., J W Mier, Hon–Wai Koon, et al.. (2004). Tolerability and anti-tumor activity of recombinant human IL-18 (rhIL-18) administered as five daily intravenous infusions in patients with solid tumors. Journal of Clinical Oncology. 22(14_suppl). 2553–2553. 1 indexed citations

Robertson, Michael J., J W Mier, Theodore F. Logan, et al.. (2004). Tolerability and anti-tumor activity of recombinant human IL-18 (rhIL-18) administered as five daily intravenous infusions in patients with solid tumors. Journal of Clinical Oncology. 22(14_suppl). 2553–2553. 9 indexed citations

Lewis, Nicole, Jared Gollob, Roger B. Cohen, et al.. (2004). Phase I dose escalation study to assess tolerability and pharmacokinetics of recombinant human IL-18 (rhIL-18) administered as fourteen daily subcutaneous injections in patients with solid tumors. Journal of Clinical Oncology. 22(14_suppl). 2591–2591. 1 indexed citations

Lacey, Simon F., Kent J. Weinhold, Chin‐Ho Chen, et al.. (1998). Herpesvirus Saimiri Transformation of HIV Type 1 Suppressive CD8 ⁺ Lymphocytes from an HIV Type 1-Infected Asymptomatic Individual. AIDS Research and Human Retroviruses. 14(6). 521–531. 17 indexed citations

Toso, John, Coreen Oei, James Tartaglia, et al.. (1996). MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.. PubMed. 56(1). 16–20. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact